Comparison of sputum induction (SI) with fiberoptic bronchoscopy (BFC) in the diagnosis of pulmonary tuberculosis (PTB) Source: Eur Respir J 2001; 18: Suppl. 33, 361s Year: 2001
A gene network to predict the clinical response to whole lung lavage (WLL), in pulmonary alveolar proteinosis (PAP). Source: International Congress 2017 – Novel and old entities Year: 2017
Active bronchial tuberculosis (ABT) among different forms of pulmonary tuberculosis (PT). The retrospective analysis of bronchoscopy data 1998-2001. Source: Eur Respir J 2002; 20: Suppl. 38, 554s Year: 2002
Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by mycobacterium avium-intracellulare complex (MAC) infection Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003
Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa ) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011
The role of fibreoptic bronchoscopy (FOB) in the diagnosis of active bronchial tuberculosis (ABT) Source: Eur Respir J 2001; 18: Suppl. 33, 497s Year: 2001
Diagnostic contribution of bronchoscopy and bronchial lavage (BL) in pulmonary tuberculosis Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Microarray and protein biomarker analysis of endobronchial epithelial lining fluid (EELF) in the evaluation of indeterminate pulmonary nodules (IPN) Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
Clinical significance of Mycobacterium tuberculosis (MBT) DNA detection in bronchoalveolar lavage and bronchial biopsy in HIV-infected patients Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
The typing of cells in the induced sputum (IS) and its apoptosis in patients with bronchial asthma (BA) Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Bio-Chip (BCh) technology for diagnostics of multidrug resistance (DR) of mycobacterium tuberculosis (MBT) from patients with disseminated tuberculosis (DT) Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD) Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
Characterization of the gene network driving the whole lung lavage (WLL) outcome in Pulmonary Alveolar Proteinosis (PAP). Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018
Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT) Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures Source: International Congress 2016 – Orphan diseases I Year: 2016
Reduction of the cost associated with exacerbations after treatment with nebulized sodium colistimethate (Promixin®) in patients with bronchiectasis (BQ) and chronic bronchial infection (CBI) with Pseudomonas aeruginosa (PsA). Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017
Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007
The utility of a serodiagnosis for mycobacterium avium complex pulmonary disease diagnosed by the single available bronchial wash Source: Eur Respir J 2004; 24: Suppl. 48, 206s Year: 2004